Drug & medication recalls Moderate risk

Sermorelin 6 mg and Sermorelin 6 mg/GHRP-2 Injection recalled over sterility concerns

Recall date
July 19, 2016
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
Talon Compounding Pharmacy recalls Sermorelin 6 mg and Sermorelin 6 mg/GHRP-2 Injection, 12 mg, 10 ml depyrogenated vials, Rx Only, Compounded by Talon Co…
Recall number
D-1463-2016
FDA classification
Class II
Brand / firm
Talon Compounding Pharmacy
Sold / distributed
Nationwide

Why it was recalled

Lack of Assurance of Sterility

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Sermorelin 6 mg and Sermorelin 6 mg/GHRP-2 Injection, 12 mg, 10 ml depyrogenated vials, Rx Only, Compounded by Talon Compounding Pharmacy, San Antonio, TX 78247

Get recall alerts

Free email alert whenever Talon Compounding Pharmacy has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Talon Compounding Pharmacy